News
58mon MSN
COVID-19 patients who are vaccinated -- and were hospitalized with reduced kidney function -- had better outcomes than unvaccinated patients, a new study finds.
There is no “the” vaccine. There are at least two mRNA vaccines (Moderna and Pfizer) and a number of different non-mRNA vaccines. In the United States a Johnson & Johnson vaccine was among the first ...
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
The Cedar Rapids Gazette reports that an unvaccinated child was infected with measles while visiting another county, and then ...
The protests are a widespread rebuke of Trump’s immigration policies. The president won the election on a pledge to conduct mass deportations, and he has used cinematic raids to signal he’s making ...
13d
What to Expect on MSNShould Pregnant Women Still Get the COVID-19 Vaccine?Here’s everything parents should know about the COVID-19 vaccines for pregnant women, including why it's still an important way to protect yourself and your baby. Should I get t ...
A damning new report by US Senator Ron Johnson reveals that American authorities were alerted to a potential link between the ...
17d
Harrogate Advertiser on MSNGolf round-up: The latest news from Harrogate & district's coursesThe last Midweek Stableford of April drew a very healthy field of 56 entrants and there was tough competition for the ...
On Wednesday, 28 May 2025, Johnson & Johnson (NYSE:JNJ) presented at the Bernstein 41st Annual Strategic Decisions Conference. Chairman and CEO Joaquin Guato and CFO Joe Wall discussed the company ...
Dakota Johnson recalled how her father, Don Johnson, had cut her off financially after she didn't get into college. While being interviewed by her "Materialists" co-star Pedro Pascal for Elle UK ...
DALLAS--(BUSINESS WIRE)--Following a third failed bankruptcy maneuver by Johnson & Johnson (NYSE: JNJ), trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf ...
Although pharma sector rival Abbott Labs (53 years) is also a dividend king, Johnson & Johnson’s 63 years of dividend hikes in a row as of 2025, tops it by a decade. A stock’s payout ratio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results